Menu
GWAS Study

Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals.

Kosmicki JA, Horowitz JE, Banerjee N et al.

34115965 PubMed ID
GWAS Study Type
586157 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KJ
Kosmicki JA
HJ
Horowitz JE
BN
Banerjee N
LR
Lanche R
MA
Marcketta A
ME
Maxwell E
BX
Bai X
SD
Sun D
BJ
Backman JD
SD
Sharma D
KF
Kury FSP
KH
Kang HM
OC
O'Dushlaine C
YA
Yadav A
MA
Mansfield AJ
LA
Li AH
WK
Watanabe K
GL
Gurski L
MS
McCarthy SE
LA
Locke AE
KS
Khalid S
OS
O'Keeffe S
MJ
Mbatchou J
CO
Chazara O
HY
Huang Y
KE
Kvikstad E
OA
O'Neill A
NP
Nioi P
PM
Parker MM
PS
Petrovski S
RH
Runz H
SJ
Szustakowski JD
WQ
Wang Q
WE
Wong E
CA
Cordova-Palomera A
SE
Smith EN
SS
Szalma S
ZX
Zheng X
ES
Esmaeeli S
DJ
Davis JW
LY
Lai YP
CX
Chen X
JA
Justice AE
LJ
Leader JB
MT
Mirshahi T
CD
Carey DJ
VA
Verma A
SG
Sirugo G
RM
Ritchie MD
RD
Rader DJ
PG
Povysil G
GD
Goldstein DB
KK
Kiryluk K
PE
Pairo-Castineira E
RK
Rawlik K
PD
Pasko D
WS
Walker S
MA
Meynert A
KA
Kousathanas A
ML
Moutsianas L
TA
Tenesa A
CM
Caulfield M
SR
Scott R
WJ
Wilson JF
BJ
Baillie JK
BG
Butler-Laporte G
NT
Nakanishi T
LM
Lathrop M
RJ
Richards JB
JM
Jones M
BS
Balasubramanian S
SW
Salerno W
SA
Shuldiner AR
MJ
Marchini J
OJ
Overton JD
HL
Habegger L
CM
Cantor MN
RJ
Reid JG
BA
Baras A
AG
Abecasis GR
FM
Ferreira MAR
Chapter II

Abstract

Summary of the research findings

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), a respiratory illness that can result in hospitalization or death. We used exome sequence data to investigate associations between rare genetic variants and seven COVID-19 outcomes in 586,157 individuals, including 20,952 with COVID-19. After accounting for multiple testing, we did not identify any clear associations with rare variants either exome wide or when specifically focusing on (1) 13 interferon pathway genes in which rare deleterious variants have been reported in individuals with severe COVID-19, (2) 281 genes located in susceptibility loci identified by the COVID-19 Host Genetics Initiative, or (3) 32 additional genes of immunologic relevance and/or therapeutic potential. Our analyses indicate there are no significant associations with rare protein-coding variants with detectable effect sizes at our current sample sizes. Analyses will be updated as additional data become available, and results are publicly available through the Regeneron Genetics Center COVID-19 Results Browser.

1,146 African ancestry cases, 21,959 African ancestry controls, 88 Admixed American cases, 1,307 Admixed American controls, 80 East Asian ancestry cases, 2,085 East Asian ancestry controls, 18,920 European ancestry cases, 530,629 European ancestry controls, 718 South Asian ancestry cases, 9,225 South Asian ancestry controls

Chapter III

Study Statistics

Key metrics and study information

586157
Total Participants
GWAS
Study Type
No
Replicated
African unspecified, Hispanic or Latin American, East Asian, European, South Asian
Ancestry
U.S., U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.